Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
Subpotent Drug: Assay below the approved specification
Subpotent Drug: Assay below the approved specification
Subpotent Drug: Assay below the approved specification
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets…
Subpotent Drug: Assay below the approved specification
Defective container; blister packaging inadequately sealed.
Defective container; blister packaging inadequately sealed.
Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
Labeling: Incorrect or Missing Lot and/or Exp.
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability…
Failed Impurities/Degradation Specifications.
Presence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.
Failed Impurities/Degradation Specifications.
Subpotent Drug
Microbial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.
Microbial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.